Table Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines

Similar documents
CHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.

Immunizations for Children and Teens with Suppressed Immune Systems

VACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.

Vaccines and other immunological antimicrobial therapy 1

TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF

Sanofi Pasteur: A partner in eradicating vaccine preventable diseases and improving access to vaccines

Procedure/Product Code Description

Stainless-steel vs Single-use: The Vaccines Perspective

Recommended Health Screenings

BODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES

Immunizations are among the most cost effective and widely used public health interventions.

Adolescent vaccination strategies

2016/17 Vaccination and Immunisation list of additional services and enhanced services

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines

1 Principles of Vaccination Immunology and Vaccine-Preventable Diseases... 1 Classification of Vaccines... 4 Selected References...

Vaccine Technologies and Global Markets

Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate Director, Emory Vaccine Center

CURRENT DEVELOPMENT IN PEDIATRIC VACCINATION

A. Children born in 1942 B. Children born in 1982 C. Children born in 2000 D. Children born in 2010

Copyright regulations Warning

Medical Coverage Guidelines are subject to change as new information becomes available.

Communicable Disease & Immunization

History and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8

Healthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.

2017/18 Immunisation programmes list of additional and enhanced services

Vaccinations for Adults

2018/19 Immunisation programmes list of additional and enhanced services

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

Achievements in Public Health, Impact of Vaccines Universal... Children -- United States,

The administration of covered immunizations and vaccines also is covered.

Economic aspects of viral hepatitis in Turkey. Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009

Appendix An Assessment Tool to Determine the Validity of Vaccine Doses

Guidelines for Vaccinating Pregnant Women

Contents. Part One Vaccine Use. Acknowledgments

How and Why Vaccines Are Developed by Industry. Stanley A. Plotkin

Family and Travel Vaccinations

Role of Partnerships in Developing Innovative Vaccines: Brazil

Centers for Disease Control and Prevention. Final Revised Vaccine Information Materials for MMR

CPT 2016 Code Changes

Guidelines for Vaccinating Pregnant Women

Immunization Update & focus on meningococcal vaccine PART 1

Annex 1. WHO Recommendations, Guidelines and other documents related to the manufacture and quality control of biological substances used in medicine

9/10/2018. Principles of Vaccination. Immunity. Antigen. September 2018

Economics of Vaccine Development A Vaccine Manufacturer s Perspective

Practical Applications of Immunology. Chapter 18

Immunization Guidelines for the Use of State Supplied Vaccine April 18, 2013

Coverage of Vaccines Medicaid and Child Health Plus Members

PATH Quick Reference Guide: Coding for Pediatric Health HEDIS Measures

New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines

Immunization Guidelines For the Use of State Supplied Vaccine July 1, 2011

Objectives. Immunity. Childhood Immunization Risk of Non-Vaccinated Children 12/22/2015

AKE WITH Y KEEP AND T

Armed Services Blood Program Immunization List

What DO the childhood immunization footnotes reveal? Questions and answers

Immunizations (Guideline Intervals Using The Rule of Six for Vaccines Birth to Six Years)

Trends in vaccinology

Immunization Records. childrens.memorialhermann.org CARE /13

The administration of covered immunizations and vaccines also is covered.

These slides are the property of the presenter. Do not duplicate without express written consent.

Vaccination-Strategies

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.

Immunizations June 5, Brenda Ormesher, MD Infectious Disease Peacehealth Medical Group Springfield, OR

Preventative Vaccines. Vaccines for Special Populations. Vaccinations for Adults: An Update. Vaccines Generally Available in the U.S.

Immunization Policy. Howard Heller, MD MPH MIT Medical

Advisory Committee on Immunization Practices VACCINE ACRONYMS

UNIVERSITY OF UTAH INTERNATIONAL TRAVEL CLINIC Phone: Fax: N Medical Dr. Salt Lake City, UT 84132

Benefit Interpretation

RECOMMENDED IMMUNIZATIONS

Young Adults (Ages 18 26)

7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.

VACCINE FACT BOOK 2012

ANNUAL HEALTH SCREENINGS AND IMMUNIZATIONS GUIDE MEN WOMEN ALL ADULTS CHILDREN

Cigna Drug and Biologic Coverage Policy

National Vaccine Plan: From Strategy to Implementation

By:Reham Alahmadi NOV The production of antibodies and vaccination technology

Centers for Disease Control and Prevention. Proposed Revised Vaccine Information Materials for MMR

Vaccines: Heroes or Villains?

Creating VaCCines, ProteCting Life

Global Health Policy: Vaccines

Recent trends on traveler s vaccinations in Japan

Vaccine. Specific defenses Immunity. natural. acquired. Live vaccines. Killed Inactivated vaccines. Cellular fraction vaccines

Please read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture. Chapters 9, 17 and 8 for next Friday s lectures

Birth 6 wk 10 wk 14 wk 18 wk 6 mo 9 mo 12 mo 15 mo 18 mo mo 2-3 Yr 4-6 Yr 7-10Yr Yr 13-18Yr

Child Health and Disability Prevention (CHDP) Program Code Conversion

Preventive Care and Monitoring of the IBD Patient

Selected vaccine introduction status into routine immunization

APPENDIX EE VACCINE STATUS AND DATE

Immunization Guidelines for the Use of State Supplied Vaccine May 17, 2015

Stanley A. Plotkin ADVAC /10/2010 2:35 PM

Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

What are the new active vaccine recommendations in the Canadian Immunization Guide?

Routine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules

2015 Vaccine Preventable Disease Summary

Part 1: Vaccine-Preventable Diseases and Childhood Vaccines

Vaccination and Immunity

Transcription:

Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND TRENDS Introduction to Vaccines THE IMMUNE RESPONSE MECHANISM OF ACTION (Table) Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2011 A BRIEF HISTORY: THE DEVELOPMENT OF VACCINES TYPES OF VACCINES Attenuated (Weakened) Live Viruses (Table) Vaccine-Preventable Diseases, August 2012 Killed (Inactivated) Viruses Toxoid Vaccines Genetically Engineered/Modified Vaccines VACCINE APPROVAL PROCESS (Table) VAERS Table of Reportable Events Following Vaccination Pediatric Preventive Vaccines INTRODUCTION (Table) Global Immunization Rates by Vaccine Type 2010 CHILDHOOD IMMUNIZATION IN THE UNITED STATES (Table) Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1990-2010 Childhood Immunization Rates Challenges to the Vaccine Delivery System The Effect of U.S. Healthcare Reform Recommended Childhood Immunization Schedule (Table) U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2012 (Table) U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2012 State Immunization Recommendations United Nations Initiatives PEDIATRIC VACCINE PRODUCTS BCG Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio Haemophilus Influenzae Type B Hepatitis A

Measles, Mumps and Rubella Meningococcal Disease Pneumococcal Conjugate Rotavirus Varicella PEDIATRIC VACCINES IN DEVELOPMENT COST OF VACCINES IN THE UNITED STATES (Table) Selected Pediatric Vaccines in Development, August 2012 THEWORLD MARKET FOR PEDIATRIC PREVENTIVE VACCINES Total Market Size and Forecast (Table) World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others) 2007-2016 Revenues (in millions) (Table) World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2006-2015 Revenues (in millions) Hepatitis Vaccine Market (Table) World Pediatric Hepatitis Vaccine Market 2007-2016 Haemophilus Influenzae Type B Vaccine Market (Table) World Hib Vaccine Market, 2007-2016 Measles, Mumps and Rubella Vaccines (Table) World MMR Vaccines Market 2007-2016 Combination Vaccines Market (Table) World Combination Vaccines Market 2007-2016 Pneumococcal Vaccine (Table) World Pediatric Pneumococcal Vaccine Market 2007-2016 Poliovirus Vaccine (Table) World Poliovirus Vaccine Market 2007-2016 Varicella Vaccines (Table) World Varicella Vaccine Market 2007-2016 Other Vaccines Market (Table) World Pediatric Other Vaccines Market 2007-2016 Adult Preventive Vaccines INTRODUCTION ADULT VACCINE-PREVENTABLE DISEASES: FACTS AND FIGURES GLOBAL INFLUENZA SURVEILLANCE PROGRAM U.S. Surveillance RECOMMENDATIONS FOR ADULT IMMUNIZATIONS (Table) Universal Adult Immunization Schedule 2012 (Table) Summary of Recommendations for Adult Immunization ADULT VACCINE PRODUCTS Cervical Cancer (Table) Initiatives to Require HPV Vaccination by U.S. State, 2012 Cholera Diphtheria-Tetanus Hepatitis Influenza

(Table) WHO Pandemic Classification Schedule Japanese Encephalitis Pneumococcal Disease Rabies Shingles Typhoid Fever Yellow Fever ADULT VACCINES IN DEVELOPMENT (Table) Selected Adult Preventive Vaccines in Development, 2012 THEWORLD MARKET FOR ADULT PREVENTIVE VACCINES Total Market Size and Forecast (Table) World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2007-2016 Revenues (in millions) (Table) World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2007-2016 Revenues (in millions) Cervical Cancer Market (Table) World Cervical CancerVaccine Market 2007-2016 Hepatitis Market (Table) World Hepatitis Vaccine Market 2007-2016 Influenza Vaccine Market (Table) World Influenza Vaccine Market 2007-2016 (Table) 2011 Estimated Population by Region and Selected Age Group (in millions) (Table) World Pneumococcal Vaccine Market 2007-2016 Travel, DT, and Miscellaneous Vaccine Market (Table) World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2007-2016 Vaccines Market Summary TRENDS DRIVING THE VACCINES MARKET MARKET SIZE AND FORECAST (Table) The World Vaccines Market by Vaccine Type 2007-2016 Revenues (in millions) Vaccine Sales by Region Vaccine Market Competitors (Table) The World Vaccines Market by Region (U.S., North America, South America, EU, Japan, India, China, ROW) 2007-2016 Revenues in millions (Table) Major Manufacturers' Shares of the World Vaccine Market, 2011 Pediatric Vaccines (Table) Major Manufacturer's Shares of the World Pediatric Vaccine Market 2011 Adult Vaccines (Table) Major Manufacturer's Shares of the World Adult Vaccine Market 2011 Issues and Trends VACCINE SAFETY Refusal to Immunize Obesity Post-Licensure Surveillance The Vaccine Injury Compensation Program

World Health Organization Other Initiatives The Future of Vaccine Safety VACCINE SHORTAGES Preventing Shortages in the Developed Countries Preventing Shortages in Developing Nations PREVENTING PANDEMICS U.S. National Vaccine Plan VACCINES AND BIOTERRORISM Overview Project Bioshield Act (Table) Selected Companies/Laboratories Developing Biodefense Vaccines National Bio and Agro-Defense Facility Vaccine Treatment and Evaluation Units Anthrax Smallpox DNA VACCINATION INNOVATIONS IN VACCINE DELIVERY SYSTEMS Mucosal Delivery Intranasal Delivery Vaccine Patches Vaccine Chips and Microneedles INNOVATIONS IN VACCINE PRODUCTION Plants Insects Nanoparticle Systems Cloning Company Profiles ALPHAVAX, INC. BAVARIAN NORDIC A/S BAXTER HEALTHCARE BHARAT BIOTECH

CRUCELL /JOHNSON &JOHNSON EMERGENT BIOSOLUTIONS Financial GLAXOSMITHKLINE MEDIMMUNE MERCK&CO. INC NOVARTIS SANOFI PASTEUR Company Directory